October is the beginning of flu season and medical offices, hospitals and clinics, schools and employers around the country are now... Read more »
It is very common for a woman with rheumatoid arthritis to suffer a disease flare within three months of the delivery of the baby. ... Read more »
On May 20, 2006, The Wall Street Journal (WSJ) ran a story about the drug choices available to people with RA. To read the story, visit... Read more »
On December 19, 2006, the United States Food and Drug Administration issued an “Alert” regarding the safety of Rituxan use in patients... Read more »
The recent meeting of the European League Against Rheumatism (EULAR) continued to present more data on the tumor necrosis factor (TNF)... Read more »
On May 20, 2006, The Wall Street Journal (WSJ) ran a story about the drug choices available to people with RA. Reporter David Hamilton reviews the... Read more »
A new rheumatoid arthritis (RA) medication being tested by Regeneron Pharmaceuticals and Sanofi has shown positive results in a recent clinical... Read more »
A review of previous studies has found a link between the use of tumor necrosis factor (TNF) inhibitors such as Remicade (infliximab), Enbrel... Read more »
According to a new study, tumor necrosis factor (TNF) inhibitors and the antimalarial medication hydroxychloroquine used by many patients with... Read more »
A new medication called fostamatinib has shown promise in a new study, researchers say. The drug is one of a new class of drugs known as spleen... Read more »